Abiomed (ABMD) Q1 Revenue Misses, Guides FY Revenue Below Consensus
Tweet Send to a Friend
Abiomed (NASDAQ: ABMD) reported Q1 EPS of $1.93, may not compare to the analyst estimate of $0.97. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
